Guillain - Barre Syndrome - is an acute frequently severe and
|
|
- Arron Joseph
- 6 years ago
- Views:
Transcription
1 12 JAPI march 2013 VOL. 61 Original Article Clinical Profile of Guillain Barre Syndrome Shubhangi Vithal Dhadke 1, Vithal Narayan Dhadke 2, Sachin S Bangar 1, Milind B Korade 3 Abstract Objectives: To study clinical presentation, hospital care and outcome of patients of Guillain Barre Syndrome (GBS) and number of patients of respiratory failure and need for ventilators. To study efficacy of IVIg in patients of GBS. Material and Methods: 40 patients of GBS studied in detail including history, clinical examination and investigations {Nerve conduction velocity and C.S.F. examination}. All patients were watched for respiratory insufficiency and those who developed respiratory paralysis were given assisted mechanical ventilation. Patients were treated with IVIG and outcome was observed. Outcome of 2 groups of patients one treated with IVIg and other not treated with IVIg (supportive line of treatment) were compared. Results: Commonest age group affected was yrs. The male:female ratio was 1.5:1. Antecedent infection in form of fever, cough [11 patients], loose motions [10 patients] were present in 21 out of 40 patients. Quadriparesis was present in 39 patients and paraparesis in 1 patient. Cranial nerve involvement was seen in 25 out of 40 patients. Facial nerve was involved in 12[30%] patients and Glossopharyengeal, vagus nerves were involved in 12[30%] patients. Areflexia was found in all 40 patients. In CSF examination, albuminocytologic dissociation was present in 17 out of 26 patients. NCV findings show conduction velocity slowing, delayed f latencies in 90% patients. Out of 40 patients,13[30%] required mechanical ventilation. Out of 40 patients, 14 were treated with IVIg, 4 patients treated with plasmapheresis and 22 patients received only supportive treatment. Out of 40 patients 30 [75%] patients recovered completely, 8 [20%] patients died and 2 [5%] patients developed severe neurologic deficit. Conclusion: GBS is more common in yrs age group with male:female ratio of 1.5:1. Antecedent infection is seen in 55% patients. Commonest presentation was paresthesia in legs and ascending paralysis. One third [32.5%] patients developed respiratory paralysis and needed ventilatory support. Patients who received IVIg early in the course of disease had faster recovery as compared to patients who received only supportive line of treatment. Introduction Guillain - Barre Syndrome - is an acute frequently severe and type of polyradiculoneuropathy of autoimmune in nature. 1 It is also known as Landry s Paralysis. 2 Guillain - Barre (Ghee-yan-Bah-ray) Syndrome is also known as acute inflammatory demyelinating polyneuropathy (AIDP) and it is an inflammatory disorder of the peripheral nerves. 1 GBS manifests as rapidly evolving areflexic motor paralysis with or without sensory disturbance. The usual pattern is an ascending flaccid paralysis. Weakness typically evolve over hours to a few days and is frequently accompanied by tingling dysaesthesias in the extremities. 6 Autonomic involvement is common. The usual manifestations are loss of vasomotor control with wide fluctuation in blood pressure, postural hypotension and cardiac arrhythmias. Respiratory failure occurred and ventilatory assistance was required in 30% cases. 1,3,5 Aetiology of GBS is not known but about 70% cases were preceded 1 to 3 wks before GBS by acute infectious process, which is usually respiratory or gastrointestinal. The theories suggest an autoimmune mechanism in which the patient s defense system of antibodies and WBC are triggered into damaging the nerve coverings or insulation leading to weakness and abnormal sensation. 1,3,5,6 1 Lecturer in Medicine Department, 2 Head of Department Medicine, 3 Senior Resident, Dept. of Medicine, Dr. V.M. Govt. Medical College, Solapur. Received: ; Revised: ; Re-revised: ; Accepted: To confirm diagnosis nerve conduction velocity (NCV) was performed. These patients NCV show conduction velocity slowing, conduction block, prolonged distal latency. In patients with Axonal form, NCV show reduced compound muscle action potential without conduction velocity slowing. 1,3,5 Treatment part includes supportive care, IVIG and Plasmapheresis. Aims and Objectives 1. To study clinical presentation, Hospital course and outcome in patients of Guillain-Barre syndrome admitted in tertiary care institute. 2. To study the number of patients developing respiratory failure and requiring artificial ventilation. 3. To study the efficacy of Intravenous Immunoglobulin in GBS patients. Material and Methods The present study includes 40 cases of GBS during the period of Jan-2008 to Sep Patients were examined clinically. Investigations were done in the form of Hemogram, Peripheral Smear examination, Renal Function Test including Serum electrolytes in all patients. CSF examination was done for albumino - Cytological dissociation and the diagnosis was confirmed by nerve conduction velocity studies (NCV). All the patients were monitored for respiratory insufficiency and those who developed Respiratory paralysis were treated with mechanical ventilation. Few patients were treated with IVIG, and few with Plasmapheresis. 168 JAPI march 2013 VOL. 61
2 JAPI march 2013 VOL The outcome of two groups of patients, one treated with IVIg and other not treated with IVIg (with supportive line of treatment) was compared. Patient who recovered and discharged were followed up on Out Patients (OPD) basis. The outcome was graded as sequelae. 1. Complete Recovery 2. Minor Sequelae 3. Major Sequelae Bed-ridden Patient and cannot carry out routine activities Inclusion Criterion of GBS Required 1. Progressive weakness of 2 or more limbs due to neuropathy. 2. Areflexia 3. Disease course less than 4 weeks. 4. Exclusion of other causes eg. (a) vasculitis- (polyarteritis nodsa, SLE), (b) toxins (organophosphates, lead) botulism, diphtheria, porphyria) Supportive 1. Relative symmetric weakness. 2. Mild sensory involvement. 3. Facial nerve or other cranial nerve involvement 4. Absence of fever at onset. 5. Typical CSF profile (acellular, increase in protein levels). 6. Electrophysiological evidence of demyelination. Results Table 1 : Age and sex distribution Age Male Female Total More than Total Table 2 : Antecedent events in the patients studied Illness Male Female Total Fever, Cough Loose motions, Vomiting Vaccinations Exanthematous Fever Total Table 3 : Duration between preceding illness and onset of symptoms Onset of weakness Male Female Total 1 Week Week Week Week Months Total Table 4 : Clinical Features Clinical Features Male Female Total Quadriparesis Paraparesis Cranial Involvement Bladder Involvement Sensory Symptom Sensory Signs Atypical presentation (Descending Paralysis) Respiratory Paralysis Fisher Variant Table 5 : Cranial nerve involvement Cranial Nerve Male Female Total Occulomotor Facial-Unilateral Facial-Bilateral Glossopharyngeal, Vagus Spinal Accessory Hypoglossal Total Table 6 : Duration of progression to respiratory paralysis during the course of illness Duration Male Female Total <1 week of onset of weakness weeks More than (>) 2 weeks Table 7 : Various signs encountered in the patients Signs Male Female Total Areflexia Sensory abnormalities Sphincter disturbances Wasting Table 8 : Investigation chart Investigation Abnormal Normal Total CSF Routine Blood Chemistry (BSL, LFT, KFT) NCV Table 9 : Electrophysiological abnormalities (NCV studies) in the patients Parameters No. of patients (40) Percentage Absent/delayed f-wave latencies 36 90% Conduction velocity slowing 36 90% Prolonged distal motor latencies 34 85% Reduced CMAP amplitudes % Absent/reduced SNAPs 28 70% No abnormality 0 0% Absent/Delayed F wave latencies Decreased conduction velocity 34 Prolonged distal motor latencies 35 Reduced CMAP 28 Absent/reduced SNAPs 0 No abnormality Graph representing Electrophysiological Abnormalities in NCV Studies JAPI march 2013 VOL
3 14 JAPI march 2013 VOL. 61 Table 10 : Modalities of treatment and outcome Treatment Total Improved Death Severe Neurodeficit Percentage of Improved Patients IVIG % Plasmapheresis % Supportive % Table 11 : Rapid progression Improved Severe Neurodeficit Death Male Female Total [11] The present study was undertaken during the period of Jan-2008 to Sep The study comprises of 40 patients with Acute Inflammatory Demyelinating Polyneuropathy. There were 24 males and 16 Females (M:F=1:5:1) their ages ranged from 13 yrs to 65 yrs, as given in Table 1. Maximum number of patient i.e. 12 (30%) were between yr. of age group. Next common age group was of years in which 11 (27.5) patients were seen, as evident from table 1. Youngest patients was 13 year old female and oldest was 65 year old female. Table 2 gives antecedent event in patients of GBS studied in which, Twenty two patients (55%) had preceding illness. Majority of the patients i.e. 11(50%) had respiratory infection as evidenced by fever and cough. Gastrointestinal infection was encountered in 10 (45%) patients. One patient had exanthematous fever in the form of measles preceding AIDP with respiratory failure. As is evident from the Table 3, majority i.e. 20 out of 22 (90.90%) patients developed neurologic illness within 4 weeks of antecedent event, while remaining 2 patients developed it between 1-3 months of preceding illness. According to Table 4, the most common clinical feature was observed quadriparesis in 39 (97.5 %) patients. The least common clinical feature observed was paraparesis in 1 (2.5%) patient. Cranial nerves involvement observed in 25 (62.5%) patients, facial nerve was the commonest. Respiratory paralysis occurred in 13 (32.5%) patients. Table 5 indicates involvement of cranial nerves in which commonest cranial nerve involved was facial in 12 [48%] patients. Bilateral Facial nerve involvement was observed in 11 patients. Glossopharyngeal and vagus nerve was involved in 12 [48%] patients, while Hypoglossal and spinal accessory nerve involvement were not seen. Occulomotor nerve involvement was seen in 1 patient. As per Table 6, out of 40 patients, 13(32.5%) had respiratory paralysis during the course of illness. Out of 13 patients 11 [ 84.61%] required respiratory support within one week of onset of weakness. Mean time was 4th day of weakness while only 2 patients required ventilatory support within 1-2 weeks of onset of weakness. As per Table 7, Areflexia is observed in all patients (100%). Wasting particularly of distal muscle was noted in 2(5%) patients at the end of 6 months. According to Table 8, nerve conduction studies were abnormal in 40 patients (100%). Table 9 indicates electrophysiological abnormalities in NCV studies in which, out of 40 patients, 36 (90%) patients had absent / delayed f-wave latencies and slowing of conduction velocity, which was the most common abnormality observed. As per Table 10, out of 40 patients, 22 patients received supportive line of treatment. Out of 22, 15(68.18%) patients improved and 2(5%) patients developed severe neurodeficit at the end of 6 months and 5 patients died. Out of 40 patients, 14 patients received IVIG. Out of 14, 11 (78.57%) patients improved and 3 patients died, 4 patients received Plasmapheresis and all survived (100%). Out of 40 patients, 30 (75%) patients improved and 2(5%) patients developed significant residual neurodeficit at the end of 6 months. 8(20%) patients died due to ventilator associated pneumonia (VAP) and sepsis. All 8 patients were on ventillators. Out of 8 patients, 6 patients age was more than 40 years. Rapid Progression Reaching Maximal Neurodeficit in 7 days. Accordng to Table 11, 11 patients had progression reaching maximal deficit in 7 days. Out of 11, 4 [36.36%] patients improved, 2[ 18.18%] patients had severe neurologic deficit and 5 [45.45%] patients died. So rapid progression reaching maximal neurodeficit in 7 days was the reason of mortality. Discussion Acute Inflammatory Demyelinating Polyneuropathy (AIDP) is the most common form of acute neuromuscular disorder encountered in clinical practice. It is obvious from various studies, that the average incidence of Guillain Barre Syndrome is 0.4 to 1.7 per 1,00,000 population. It is fairly same in so many different geographical areas (Sweden, Italy, UK and U.S.A.) 2 In our study, 40 cases were studied in a span of 2 years hence it is insufficient to predict incidence of GBS from it in this area. Age Prevalence GBS seems to affect all the age groups. However there are studies suggesting some more specific age distribution. Adams, Victor and Ropper have quoted age range from as small as 8 months to as old as 80 years for GBS. Kaplan et al have reported two peaks one between 15 to 35 years and the other between 50 to 75 years of age. 2,3 Jiang - Guoxin in their study in Sweden have observed two peaks one between 20 to 24 years and the other between years. 8 In our study there were maximum 12 patients were in the age group of 31 to 40 years of age. The youngest patient in our study was 13 year old girl and the oldest was 65 years old women. Sex Prevalence Roberto D Alessandro did a study in Emilia-Romagna Italy and found a significant male preponderance in GBS with male: female ratio of In our study there was a male preponderance (26 males out of total 40 case) which confirms to the findings of other studies and 14 case an males with M:F ratio was 1.5:1. History of antecedent events History of antecedent illness is indeed significant in many cases of GBS. According to study done by Winner Hughes et al in more than 50 % of cases there is a significant history of preceding illness. 11 In the our study out of 40 patients twenty two patients (55%) had history of preceding illness. 170 JAPI march 2013 VOL. 61
4 JAPI march 2013 VOL Type of antecedent illness RDM Hadden, RAC Hughes et al have mentioned that two third of the patients of GBS will develop the neurological signs and symptoms within one to two weeks from the antecedent illness. One third of these are form of respiratory infection, One fourth have diarrhoea (usually campylobacter jejuni) and one fourth have influenza like illness. Some other rarer forms of infections mentioned are cytomegalovirus infection, Ebstein Barre Virus, Varicella, HIV infections. Immunization also has been mentioned as one of the rarer triggering factors. 12 In our study the most common preceding illness (11 patients out of 22 patients) was respiratory infection (History of fever and cough). Next was gastrointestinal infection was encountered in ten patients. Duration between preceding illness and onset of weakness Rhode Island study by Gilchrist Craing Woodland, has reported the duration of 1 to 4 weeks between antecedent events and onset of weakness. 13 As is evident from the observation table No.3 in our study, majority i.e. 20 out of 22 patients developed neurological illness within 4 weeks of antecedent event while remaining 2 patients developed between 1 to 3 months. Clinical Features in the GBS Sensory symptoms Loeffel Rossi et al in 1997 reported that in 75% of the patients the first neurological symptoms was paraesthesia in the toes. 14 In our study, before the onset of weakness, sensory symptoms in the form of tingling numbness, paraesthesia or pain were observed in 13 (32.5%) of the patients. 13 Motor symptoms The muscular weakness which is classical of GBS described as ascending and symmetrical with depressed and / or absent Deep Tendon Reflexes (DTRS) this pattern has been described in more than 90 % of cases of GBS in various studies (RDM Hadden and Hughes, Rostani AM et al Brain). 14,15 The weakness is most in the proximal musculature and is accompanied with depressed or absent Deep tendon reflexes in 80% of cases. Adams and Victor have described incidence of absent or depressed reflexes as 90% and in 10% cases there may be preservation of reflexes except ankle jerk which is lost in the initial phase of illness followed by loss of other reflexes later on. Asbury and Cornblath have described motor weakness to be maximum within days and usually the progress of the weakness ceases by 4th to 6th week of onset of illness. 2,14 In our study, out of 40 patients, 39(97.5 %) patients had the most common mode of presentation is ascending paralysis leading to quadriparesis with absent Deep tendon Reflexes. Cranial nerve involvement Loeffel, Rossi et al have quoted 50 % incidence of cranial nerve palsies in GBS in which facial nerve was the commonest. 14 In our study 62.5 % of the patients had cranial nerve involvement, commonest being the facial nerve. Respiratory failure Respiratory failure is the complication of GBS, study done by RDM Hadden, RAC Hughes had 20 % of incidence, while Teitebaum J.S. et al had 10 to 30 % incidence. 16 In our study, the respiratory failure was observed s in 13 (32.5%) patients. At an average, the duration between onset of weakness and respiratory failure is reported to be between 2 to 3 weeks by Hadden and Hughes and Harish Justin et al in their independent studies. In our study, out of 13 patients. 11 had respiratory failure within first week from onset of weakness and 2 patient had it in the second week from the onset of weakness. Duration of mechanical ventilation Ropper A.H. et al studied 38 patients of GBS out of which 19 required ventilation and the mean duration was for 49 days. 17 In our study the longest duration of Ventilation was of 94 days of a 45 year old man. Out of thirteen ventilated patients in this study 11 required it for less than 15 days and one patient required it for more than two months. Laboratory evaluation of GBS Diagnosis of GBS is mainly clinical. Hadden Hughes et al and Winner Hughes et al in their independent studies show that 80 % of the times there is albumino - cytological dissociation in CSF of the patients with GBS 17 In our study out of 26 patients who underwent CSF examination, 17 had albumino-cytological dissociation. Remaining 14 patients could not be subjected to lumbar puncture due to poor general condition and or compromised spontaneous respiration. Nerve conduction velocity is considered as a very useful tool for diagnosis as well as prognostication of AIDP by many authors. 2,3 (Bradley Daraff, Loffel VB et al, John Walten) In our study out of 40 patients, 33 patients had mixed sensorimotor demyelinating neuropathy while 7 patients had pure motor neuropathy so all patients had NCV findings suggestive of GBS. Treatment Good nursing care with Intravenous Immunoglobulins or plasmapheresis is considered as effective mode of treatment of GBS by many studies (Rostani A Metal, Ranfala H et al, RDM Hadden et al) IVIG is considered as treatment of choice in GBS in the dose of 400 mg/kg/day for five days by RDM Hadden et al. 15,18 In our study out of 40 patients, 14 patients received Intravenous immunoglobulin and 4 patients received plasmapheresis while rest of the patients received general nursing care. Plasmapheresis is not available in our hospital. We referred these patients to private hospital, those who were affording. This is the only part of treatment (clinical profile of GBS). This study is too small to find out the efficacy of various treatment modalities. Outcome In general, studies done by various authors worldwide suggest a good clinical outcome from GBS. Hadden and Hughes have reported 6% mortality 15 while GDP Smith et al have quoted a mortality of 4% in their respective studies. 19 In our study out of 40 patients, there were 8 deaths (mortality of 20%). Deaths were due to ventilator associated pneumonia, sepsis, and low amplitude CMAP and patients reporting very late to hospital for admission and age more than 40 years. Neurodeficits James Mcleod et al have quoted 15 to 25% incidence of significant neurodeficit at 6th month of illness. In our study out of 40 patient 2 (5%) patients had significant residual weakness at the end of 6 months. Various Factors that Determine the Outcome Rinske Van Koningsveld, Steyerberg E W studied clinical JAPI march 2013 VOL
5 16 JAPI march 2013 VOL. 61 prognostic scoring system for patients of GBS. 20 They studied 3 variables. Age, preceding diarrhoea, and GBS disability score at 2 weeks after entry, which accurately predicts poor outcome at 6 months. In our study is too small to duplicate such a helpful prognostication method, but we can test the prognostic indicators for accuracy. In our study there were 8 deaths and all of them were treated with mechanical ventilators. So, we can say that age over 40 years and mechanical ventilation are the poor prognostic factors. Severity of the disease course, including length of the ICU and hospital stay, risk of complications and a low amplitude CMAP indicate poor prognosis. Above 40 years of age, 6 patients died. In all 8 dead patients, CMAP was low amplitude. Patients who received Intravenous Immunoglobulin early in the course of disease, had faster recovery. Only 4 patients in our study received plasmapheresis and all were recovered completely. Conclusions 1. Guillain Barre Syndrome is common more in males than females. 2. Commonest age group is between yrs of age, the youngest age is 13 years and the oldest age is 65 years. 3. History of antecedent infection (Gastrointestinal or respiratory) is seen in about 55 % of patients. 4. Commonest presentation of GBS is paresthesia in legs and ascending paralysis. 5. One third (32.5%) of patients developed respiratory paralysis and needed ventilatory support. 6. Nerve Conduction Velocity study is the most useful investigations in diagnosis and abnormal in all GBS patients. 7. Patients who received Intravenous Immunoglobulin, early in the course of disease had faster recovery as compared to patients who received only supportive line of treatment. 8. Facial nerve(bilateral) is commonly involved nerve and all patient had abnormal NCV studies. 9. Areflexia is the most common sign observed in 40 patients. (100%). 10. The most common NCV studies observed is absent / delayed f-wave latencies and slowing of conduction velocity. 11. Out of 40 patients, 32 patients improved. References 1. Hauser SL, Asbury AK. Guillain-Barre Syndrome and other immune-related neuropathies. In Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo D, Jameson JL et al. Harrison s Principles of Internal Medicine. 17th edition,vol-ii. New York: Mc Graw-Hill, 2008; Ropper AH, Brown RH. Adams and Victor s Principles of Neurology. 9th edition.new York: Mc Graw-Hill,2005; Asbury MIC.New Concepts of GBS. J Child Neurology 2000;75: Kliegman RM, Behrman RE, Jenson HB,Staton BF. Guillain Barre syndrome. Nelson Textbook of paediatrics. 18th edition, vol-ii. Philadelphia: Saunders, 2007; Donaghy M. Polyneuropathy.Brain s Diseases of Nervous system.12th Edition.New York: Oxford University press,2009; Ghai OP, Paul VK, Bagga A. Central nervous system. Essential Pediatrics. 7th Edition. New Delhi: CBS publishers and distributors 2009; Hughes RAC, Wijdicks EFM, Benson E, Cornblath DR, Hahn AF, Meythaler JM et al. Supportive care for Patients with Guillain Barre Syndrome Arch Neurol. 2005;62: Guo-Xin J. GBS in Sweden from clinical epidemiology to public health surveillance. Journal of Neurology 1996;75: Ropper AH. Guillain- Barre syndrome variants in Emilia Ramagna, Italy, : Incidence, clinical features, and prognosis. Clinical and Neurology J. Neurol. Neurosurg. Psychiatry 1998;65: Winner SJ, Evans JG. Age Specific Incidence of Guillain Barre Syndrome in Oxfordshire. QJ Med 1990;77: Jacobs BC, van dermeche FGA, Herbrink P, Schmitz PIM, de Klerk MA, van Doorn PA. The spectrum of antecedent infections in Guillain Barre Syndrome case control study. Arch Neurol 1988;45: Seneca H. Influenza; epidemiology, etiology, immunization and management. J Am Geriatrics Soc 1980;28: Louie M, Gilchrist JM, Woodward G. 5 years Rhod Island Hospital Experience GBS. The Lancet Neurology 2000;40: Loffel VB, Rossi LN, Mumenyhaler M. The Landry Gullian Barre Syndrome complication prognosis and natural History of 123 cases. J Neural SG 1977;33: Hadden RDM, Huges RAC. GBS recent advances. Arch Neurol 2008;41: Durand MC, Porcher R, Orlikowski D, Clair CD, Annane D, Jean- Louis Gaillard JL et al. Clinical and electrophysiological predictors of respiratory failure in Guillain-Barre Syndrome: a prospective study. The Lancet Neurology 2006;5: Ropper AH. Electrodiagnostic Abnormalities in 113 Consecutive Patients with Guillain Barre Syndrome Arch Neurol 1990;47: Sater RA, Rostami A. Treatment of Guillain Barre Syndrome with intravenous immunoglobulin. Neurology 1998;51:9-15.y MIC.New Concepts of GBS. J Child Neurology 2000;86: Smith GDP, Hughes RAC. Plasma exchange treatment and prognosis of GBS. Quarterly Journal of Medicine New Series 1985;306: Van Koningsveld R, Steyerberg EW, Hughes RA, Swan AV, Van doorn PA, Jacobs BC. A clinical prognostic scoring system for Guillain-Barre syndrome. Lancet Neurol 2007;6: JAPI march 2013 VOL. 61
Guillain-Barré Syndrome
Guillain-Barré Syndrome Ouch! www.philippelefevre.com Guillain-Barré Syndrome Acute post-infective polyneuropathy Heterogeneous condition with several variant forms Lipid A Neuronal Ganglioside Pathogenesis
More informationRisk Factors of Respiratory Failure in Children with Guillain-Barré Syndrome
Pediatrics and Neonatology (2012) 53, 295e299 Available online at www.sciencedirect.com journal homepage: http://www.pediatr-neonatol.com ORIGINAL ARTICLE Risk Factors of Respiratory Failure in Children
More informationThe Role of Cytomegalovirus, Haemophilus Influenzae and Epstein Barr Virus in Guillain Barre Syndrome
ORIGINAL REPORT The Role of Cytomegalovirus, Haemophilus Influenzae and Epstein Barr Virus in Guillain Barre Syndrome Shahriar Nafissi 1, Zahra Vahabi 1, Maryam Sadeghi Ghahar 2, Ali Akbar Amirzargar 2,
More informationSupplementary Online Content
Supplementary Online Content Stevens O, Claeys KG, Poesen K, Veroniek S, Van Damme P. Diagnostic challenges and clinical characteristics of hepatitis E virus associated Guillain- Barré syndrome. JAMA Neurol.
More informationElectrophysiology in the Guillain-Barré Syndrome: Study of 30 Cases
Journal of Bangladesh College of Physicians and Surgeons Vol. 24, No. 2, May 2006 Electrophysiology in the Guillain-Barré Syndrome: Study of 30 Cases NC KUNDU Summary: Thirty consecutive patients diagnosed
More informationGuillain Barre Syndrome: A clinical observational study in Indian paediatric patients
Guillain Barre Syndrome: A clinical observational study in Indian paediatric patients *Shikha Swaroop 1, Bakul B Javadekar 2 Sri Lanka Journal of Child Health, 2017; 46(3): 238-242 Abstract Background:
More informationMiller Fisher Syndrome A variant of Guillan Barré Syndrome. Sarah I. Sheikh, BM BCh, MRCP
Miller Fisher Syndrome A variant of Guillan Barré Syndrome Sarah I. Sheikh, BM BCh, MRCP History of GBS 1859 Jean Baptiste Octave Landry de Thézillat (1826-1865) published his observation on ascending
More informationImmunopathology of Guillain- Barré syndrome. L. Magy Service de Neurologie Centre de Référence 'Neuropathies Périphériques Rares' CHU Limoges, France
Immunopathology of Guillain- Barré syndrome L. Magy Service de Neurologie Centre de Référence 'Neuropathies Périphériques Rares' CHU Limoges, France What is Guillain-Barré syndrome? An immune-mediated
More informationClinical and electrophysiologic features of childhood Guillain-Barré syndrome in Northeast China
Journal of the Formosan Medical Association (2014) 113, 634e639 Available online at www.sciencedirect.com journal homepage: www.jfma-online.com ORIGINAL ARTICLE Clinical and electrophysiologic features
More informationNeuromuscular Respiratory Failure in Guillain-Barre Syndrome: Evaluation of Clinical and Electrodiagnostic Predictors
Original Article Neuromuscular Respiratory Failure in Guillain-Barre Syndrome: Evaluation of Clinical and Electrodiagnostic Predictors Uma Sundar, Elizabeth Abraham, A Gharat, ME Yeolekar, Trupti Trivedi,
More informationInternational Journal of Basic & Applied Physiology
ELECTRODIAGNOSTIC FEATURES IN CLINICALLY SUSPECTED GUILLAIN BARRE SYNDROME Asha Shrivastava*, Rashmi Dave**, Sanjeev Shrivastava ***, Brajesh Sharma **** *Professor, ** JR III, *** Assistant Professor,
More informationDysphagia as initial manifestation of Guillan-Barrè Syndrome in a child Elda Pitrolo, Simona Santucci, Chiara Cuzzupè, Filippo De Luca
Clinical Case Seminar A7(1-5 ) Dysphagia as initial manifestation of Guillan-Barrè Syndrome in a child Elda Pitrolo, Simona Santucci, Chiara Cuzzupè, Filippo De Luca Department of Human Pathology of Adulthood
More informationImmune Mediated Neuropathies
Immune Mediated Neuropathies Hernan Gatuslao, M.D. Assistant Professor Department of Neurology Virginia Commonwealth University School of Medicine AIDP and CIDP Acute inflammatory demyelinating polyneuropathy
More informationEvaluation of Peripheral Neuropathy. Evaluation of Peripheral Neuropathy - Introduction
Evaluation of Peripheral Neuropathy Chris Edwards, MD Ochsner Neurology, Main Campus Evaluation of Peripheral Neuropathy - Introduction A very common complaint in the clinic Presentation is variable Multiple
More informationCritical Illness Polyneuropathy CIP and Critical Illness Myopathy CIM. Andrzej Sladkowski
Critical Illness Polyneuropathy CIP and Critical Illness Myopathy CIM Andrzej Sladkowski Potential causes of weakness in the ICU-1 Muscle disease Critical illness myopathy Inflammatory myopathy Hypokalemic
More informationClinical and Neurophysiological Pattern of Guillain-Barré Syndrome in Diabetic and Non Diabetic Patients
Clinical and Neurophysiological Pattern of Guillain-Barré Syndrome in Diabetic and Non Diabetic Patients Shereen Zakarya Department of Neurology, Mansoura University ABSTRACT Objective: To study the clinical
More informationGUILLAIN-BARRE SYNDROME
GUILLAIN-BARRE SYNDROME tarek.sharshar@rpc.aphp.fr University of Versailles Saint-Quentin en Yvelines Raymond Poincaré Teaching Hospital Garches - France STATEMENTS 1. Guillain-Barré Syndrome (GBS) is
More informationGuillain-Barré syndrome and related disorders
Guillain-Barré syndrome and related disorders Dr Benjamin Wakerley Department of Neurology Gloucestershire Royal Hospital Disclosures Novartis - educational grant Guillain-Barré syndrome and related disorders
More informationPeripheral neuropathies, neuromuscular junction disorders, & CNS myelin diseases
Peripheral neuropathies, neuromuscular junction disorders, & CNS myelin diseases Peripheral neuropathies according to which part affected Axonal Demyelinating with axonal sparing Many times: mixed features
More informationClinical Profile of Guillain Barre Syndrome-Observations from a Tertiary Care Hospital of Bangladesh
Original Article Clinical Profile of Guillain Barre Syndrome-Observations from a Tertiary Care Hospital of Bangladesh Habib R a, Saifuddin M b, Islam R c, Rahman A d, Bhowmik NB e, Haque MA f Abstract
More informationPrediction of Functional Outcome in Axonal Guillain-Barre Syndrome Eun Jung Sung, MD, Dae Yul Kim, MD, Min Cheol Chang, MD, Eun Jae Ko, MD
Original Article Ann Rehabil Med 2016;40(3):481-488 pissn: 2234-0645 eissn: 2234-0653 http://dx.doi.org/10.5535/arm.2016.40.3.481 Annals of Rehabilitation Medicine Prediction of Functional Outcome in Axonal
More informationParaparetic Guillain-Barré syndrome
Paraparetic Guillain-Barré syndrome Bianca van den Berg, MD Christiaan Fokke, MD Judith Drenthen, MD Pieter A. van Doorn, MD, PhD Bart C. Jacobs, MD, PhD Correspondence to Dr. Jacobs: b.jacobs@erasmusmc.nl
More informationInfection-Associated Neurological Syndromes
Infection-Associated Neurological Syndromes Anand P, MD PhD Medical Director, BloodCenter of Wisconsin Assistant Professor, Medical College of Wisconsin ASFA Annual Meeting San Antonio, TX, May 8th, 2015
More informationGuillain-Barré Syndrome in a Patient with Pneumococcal Meningitis
Guillain-Barré Syndrome in a Patient with Pneumococcal Meningitis An Uncommon Complication of a Common Infection ACP Wisconsin, September 2017 Jesse Maupin, MD (PGY-2) University of Wisconsin Hospital
More informationHyperreflexia in Guillain-Barré syndrome: relation with acute motor axonal neuropathy and anti-gm1 antibody
18 Department of Neurology, Chiba University School of Medicine, Chiba, Japan S Kuwabara K Ogawara M Mori T Hattori Department of Neurology, Dokkyo University School of Medicine, Tochigi, Japan M Koga
More informationA comparison of two patients with Guillain-Barre Syndrome J O H N C O R S I N O, S P T
A comparison of two patients with Guillain-Barre Syndrome J O H N C O R S I N O, S P T Guillain-Barre Acute inflammatory demyelinating polyneuropathy Highly diverse presentation, course, outcome Miller-Fisher:
More informationAUTOIMMUNE DISORDERS IN THE ACUTE SETTING
AUTOIMMUNE DISORDERS IN THE ACUTE SETTING Diagnosis and Treatment Goals Aimee Borazanci, MD BNI Neuroimmunology Objectives Give an update on the causes for admission, clinical features, and outcomes of
More informationFrom the Department of Neurology, University Hospital Birmingham, Birmingham, UK
Q J Med 2002; 95:717 721 Review QJM Treatment of Guillain-Barré syndrome J.B. WINER From the Department of Neurology, University Hospital Birmingham, Birmingham, UK Introduction Although there are earlier
More informationA comparison between plasmapheresis and intravenous immunoglobulin in children with Guillain Barré syndrome in Upper Egypt
610471TAN0010.1177/1756285615610471Therapeutic Advances in Neurological DisordersK. Saad research-article2015 Therapeutic Advances in Neurological Disorders Original Research A comparison between plasmapheresis
More informationComparison of electrophysiological findings in axonal and demyelinating Guillain-Barre syndrome
Iranian Journal of Neurology Original Paper Iran J Neurol 2014; 13(3): 138-143 Comparison of electrophysiological findings in axonal and demyelinating Guillain-Barre syndrome Received: 9 Mar 2014 Accepted:
More informationGuillain Barré Syndrome: Profile of 120 Patients with respect to Response to Various Modalities of Treatment
IJPMR ORIGINAL ARTICLE 10.5005/jp-journals-10066-0022 Guillain Barré Syndrome Guillain Barré Syndrome: Profile of 120 Patients with respect to Response to Various Modalities of Treatment 1 Vishal A Chafale,
More informationAssociation of Campylobacter jejuni infection and Guillain- Barré syndrome: a cohort study in the northwest of Iran
The Turkish Journal of Pediatrics 2008; 50: 443-448 Original Association of Campylobacter jejuni infection and Guillain- Barré syndrome: a cohort study in the northwest of Iran Mohammad Barzegar 1, Asghar
More informationSevere Chronic Inflammatory Demyelinating Polyneuropathy Ameliorated following High-dose (3 g/kg) Intravenous Immunoglobulin Therapy
doi: 10.2169/internalmedicine.1723-18 http://internmed.jp CASE REPORT Severe Chronic Inflammatory Demyelinating Polyneuropathy Ameliorated following High-dose (3 g/kg) Intravenous Immunoglobulin Therapy
More informationA descriptive study of patients with Guillain-Barré syndrome: Experience from an Australian tertiary level hospital
A descriptive study of patients with Guillain-Barré syndrome: Experience from an Australian tertiary level hospital Emma Foster 1, Luke Bonavia 1, Ashwin Subramaniam 2-4, Cameron Green 1, Ernest Butler
More informationLE SYNDROME DE GUILLAIN-BARRE
FORMATION UNIVERSITAIRE SPECIFIQUE (FUS) Enseignement interuniversitaire MASTER DE SPECIALISATION EN MEDECINE INTERNE Samedi 19 dećembre 2015 Institute of Neurosciences LE SYNDROME DE GUILLAIN-BARRE Peter
More information5.1 Alex.
5.1 Alex http://tinyurl.com/neuromakessense Alex is a 20-year-old full-time national serviceman. His only past medical history is asthma, presents to A&E with a 4-day history of bilateral finger weakness
More informationCase Report An Unusual Case of Recurrent Guillain-Barre Syndrome of a Different Subtype Five Years after Initial Diagnosis
Case Reports in Neurological Medicine Volume 2013, Article ID 356157, 4 pages http://dx.doi.org/10.1155/2013/356157 Case Report An Unusual Case of Recurrent Guillain-Barre Syndrome of a Different Subtype
More informationExpanded Case Summary 4: Botulism.
Expanded Case Summary 4: Botulism. This case details the presentation and management of a patient admitted to the intensive care unit following a respiratory arrest with potential hypoxic brain injury.
More informationA Case of Acute Sensory Neuropathy Associated with Contrast Enhancement of the Cauda Equina on Magnetic Resonance Imaging
61 Case Report St. Marianna Med. J. Vol. 33, pp. 61 66, 2005 A Case of Acute Sensory Neuropathy Associated with Contrast Enhancement of the Cauda Equina on Magnetic Resonance Imaging Toshinari Kobayashi
More informationCorrelative study between C-reactive protein, clinical severity, and nerve conduction studies in Guillain-Barrè syndrome
Altaweel et al. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery (2018) 54:4 https://doi.org/10.1186/s41983-018-0006-2 The Egyptian Journal of Neurology, Psychiatry and Neurosurgery RESEARCH
More informationCase Number 1 Guillain-Barré Syndrome (GBS)
Case Number 1 Guillain-Barré Syndrome (GBS) Maria Angela Grima Reviewed by: Dr. Nicola Aquilina Case summary: Demographic details: Mr. JS, male, Gudja Referred from: GP A 57-year-old Caucasian gentleman
More informationGuide to the use of nerve conduction studies (NCS) & electromyography (EMG) for non-neurologists
Guide to the use of nerve conduction studies (NCS) & electromyography (EMG) for non-neurologists What is NCS/EMG? NCS examines the conduction properties of sensory and motor peripheral nerves. For both
More informationChanges in the severity and subtype of Guillain-Barré syndrome admitted to a specialist Neuromedical ICU over a 25 year period
J Neurol (2017) 264:564 569 DOI 10.1007/s00415-016-8380-0 ORIGINAL COMMUNICATION Changes in the severity and subtype of Guillain-Barré syndrome admitted to a specialist Neuromedical ICU over a 25 year
More informationAppendix I (a) Human Surveillance Case Definition (Revised July 4, 2005)
Section A: Case Definitions Appendix I (a) Human Surveillance Case Definition (Revised July 4, 2005) The current Case Definitions were drafted with available information at the time of writing. Case Definitions
More informationGuillain-Barre Syndrome and its Prognosis with Hyponatremia
Original Article RUHS Journal of Health Sciences, Volume 2 Number 4, October -December 2017 Guillain-Barre Syndrome and its Prognosis with Hyponatremia Jerin Romeol, Hemant Mahur2, D P Singh3, Nitesh Pansari4,
More informationRisk factors for respiratory failure in Guillain-Barre syndrome in Bangladesh: a prospective study
RESEARCH ARTICLE Risk factors for respiratory failure in Guillain-Barre syndrome in Bangladesh: a prospective study Zhahirul Islam 1, *, Nowshin Papri 1, *, Gulshan Ara 2, Tanveen Ishaque 1,3, Arafat U.
More informationORIGINAL CONTRIBUTION. Nicholas D. Lawn, FRACP; Dade D. Fletcher, MD; Robert D. Henderson, FRACP; Troy D. Wolter, MS; Eelco F. M.
ORIGINAL CONTRIBUTION Anticipating Mechanical Ventilation in Guillain-Barré Syndrome Nicholas D. Lawn, FRACP; Dade D. Fletcher, MD; Robert D. Henderson, FRACP; Troy D. Wolter, MS; Eelco F. M. Wijdicks,
More informationORIGINAL CONTRIBUTION. Continuous Spectrum of Pharyngeal-Cervical-Brachial Variant of Guillain-Barré Syndrome
ORIGINAL CONTRIBUTION Continuous Spectrum of Pharyngeal-Cervical-Brachial Variant of Guillain-Barré Syndrome Takahide Nagashima, MD, PhD; Michiaki Koga, MD, PhD; Masaaki Odaka, MD, PhD; Koichi Hirata,
More informationElectrodiagnostic Variations in Guillain-Barré Syndrome - Retrospective Analysis of 95 Patients
Original Article GCSMC J Med Sci Vol (VI) No (II) July-December 2017 Electrodiagnostic Variations in Guillain-Barré Syndrome - Retrospective Analysis of 95 Patients Chilvana Patel*, Surya Murthy Vishnubhakat**
More informationTUMOURS IN THE REGION OF FORAMEN MAGNUM
TUMOURS IN THE REGION OF FORAMEN MAGNUM Abstract Pages with reference to book, From 119 To 122 Naim-ur-Rahman ( Department of Neurosurgery, Rawalpindi Medical College, Rawalpindi. ) A very unusual case
More informationA CASE OF QUADRIPARE SIS. Dr Shivam Sharma Department of Medicine
A CASE OF QUADRIPARE SIS Dr Shivam Sharma Department of Medicine Clinical History A 27 yr male, shopkeeper by occupation presented with chief complaints of High grade fever with chills - 3 days Weakness
More informationCOPYRIGHT 2012 THE TRANSVERSE MYELITIS ASSOCIATION. ALL RIGHTS RESERVED
The Transverse Myelitis Association...advocating for those with acute disseminated encephalomyelitis, neuromyelitis optica, optic neuritis and transverse myelitis ACUTE DISSEMINATED ENCEPHALOMYELITIS (ADEM)
More informationUpdate: Plasmapheresis in Neurologic Disorders
Update: Plasmapheresis in Neurologic Disorders Case Presentation A 62-year-old, right-hand-dominant male presented to the emergency department with a 3-day history of progressive weakness. Initially he
More informationInternational Journal of Ayurveda and Pharmaceutical Chemistry
International Journal of Ayurveda and Pharmaceutical Chemistry Volume 7 Issue 2 2017 www.ijapc.com Managed by Green m RESEARCH ARTICLE www.ijapc.com e-issn 2350-0204 Role of an Advanced Diagnostic Technique
More informationEUROPEAN JOURNAL OF PHARMACEUTICAL AND MEDICAL RESEARCH GUILLAIN-BARRÉ SYNDROME (GBS): A REVIEW
ejpmr, 2016,3(2), 366-371 EUROPEAN JOURNAL OF PHARMACEUTICAL AND MEDICAL RESEARCH www.ejpmr.com SJIF Impact Factor 2.026 Review Article ISSN 3294-3211 EJPMR GUILLAIN-BARRÉ SYNDROME (GBS): A REVIEW Hemal
More informationCompound Action Potential, CAP
Stimulus Strength UNIVERSITY OF JORDAN FACULTY OF MEDICINE DEPARTMENT OF PHYSIOLOGY & BIOCHEMISTRY INTRODUCTION TO NEUROPHYSIOLOGY Spring, 2013 Textbook of Medical Physiology by: Guyton & Hall, 12 th edition
More informationPeripheral Neuropathies
Peripheral Neuropathies ELBA Y. GERENA MALDONADO, MD ACTING ASSISTANT PROFESSOR UNIVERSITY OF WASHINGTON MEDICAL CENTER Objectives Definition Neurophysiology Evaluation of polyneuropathies Cases Summary
More informationCIDP + MMN - how to diagnose and treat. Dr Hadi Manji
CIDP + MMN - how to diagnose and treat Dr Hadi Manji Outline Introduction CIDP Diagnosis Clinical features MRI Nerve conduction tests Lumbar puncture Nerve biopsy Treatment IV Ig Steroids Plasma Exchnage
More informationGuillain-Barré Syndrome Beth A. Rosen. DOI: /pir
Guillain-Barré Syndrome Beth A. Rosen Pediatrics in Review 2012;33;164 DOI: 10.1542/pir.33-4-164 The online version of this article, along with updated information and services, is located on the World
More informationRecognizing Guillain-Barré Syndrome in the Primary Care Setting
Internet Journal of Allied Health Sciences and Practice Volume 5 Number 1 Article 5 1-1-2007 Recognizing Guillain-Barré Syndrome in the Primary Care Setting Kristi McClellan Mantay Eastern Virginia Medical
More informationMuscle Wasting & Weakness in Critical Illness
Muscle Wasting & Weakness in Critical Illness Clin A/Prof Michael O Leary Intensive Care Service Royal Prince Alfred Hospital, Sydney Sydney Medical School, The University of Sydney Disclosures I have
More informationElectrodiagnostic studies comprising of electromyography (EMG) and nerve
INTRODUCTION AND TERMINOLOGY Electrodiagnostic studies comprising of electromyography (EMG) and nerve conduction studies (NCS) are well-established objective methods for the diagnosis, quantification and
More informationA STUDY OF ASSESSMENT IN PERIPHERAL NEUROPATHY IN PATIENTS WITH NEWLY DETECTED THYROID DISORDERS IN A TERTIARY CARE TEACHING INSTITUTE
A STUDY OF ASSESSMENT IN PERIPHERAL NEUROPATHY IN PATIENTS WITH NEWLY DETECTED THYROID DISORDERS IN A TERTIARY CARE TEACHING INSTITUTE Rajan Ganesan 1, Marimuthu Arumugam 2, Arungandhi Pachaiappan 3, Thilakavathi
More informationGuillain-Barré Syndrome: Natural history and prognostic factors: a retrospective review of 106 cases
González-Suárez et al. BMC Neurology 2013, 13:95 RESEARCH ARTICLE Open Access Guillain-Barré Syndrome: Natural history and prognostic factors: a retrospective review of 106 cases Inés González-Suárez *,
More informationEvaluation of nerve conduction abnormalities in type 2 diabetic patients
Original article: Evaluation of nerve conduction abnormalities in type 2 diabetic patients 1Kannan K, 2 Sivaraj M 1Asst Professor, Dept of Physiology, kilpauk Medical College, Kilpauk, Chennai, Tamil Nadu,
More informationNovember 16-18, 2017 Hotel Monteleone New Orleans, LA. Provided by
November 16-18, 2017 Hotel Monteleone New Orleans, LA Provided by Diabetic Neuropathy: A Global and Growing Problem John D. England, MD Louisiana State University Health Sciences Center School of Medicine
More informationZKV and Guillain-Barré Syndrome. Silvia N. Tenembaum Pediatric Neurologist
ZKV and Guillain-Barré Syndrome Silvia N. Tenembaum Pediatric Neurologist ZIKA VIRUS- BACKGROUND INFORMATION Arbovirus (Arthropod-borne virus) 1- Flaviviridae family: Dengue (DENV) West Nile (WNV) Yellow
More informationCNS third year med students Summary of midterm material H Awad
CNS third year med students 2018 Summary of midterm material H Awad Dear All This presentation summaries the main important topics covered in the midterm material ( lectures 1-6) There will be two questions
More informationACUTE SYMMETRICAL MOTOR NEUROPATHY IN DIABETES MELLITUS
Prize-Winning Paper Summary ACUTE SYMMETRICAL MOTOR NEUROPATHY IN DIABETES MELLITUS A distinct clinical entity M. Gourie Devi* The main clinical features in 12 patients with acute motor neuropathy associated
More informationORIGINAL ARTICLE. STUDY OF CLINICO ELECTROPHYSIOLOGICAL PROFILE OF DIABETIC NEUROPATHY Sachin. G. J, Ravi Vaswani, Shilpa. B.
STUDY OF CLINICO ELECTROPHYSIOLOGICAL PROFILE OF DIABETIC NEUROPATHY Sachin. G. J, Ravi Vaswani, Shilpa. B. 1. Assistant Professor, Department of Medicine, Vijayanagara Institute of Medical Sciences. Bellary.
More informationA/Professor Arun Aggarwal Balmain Hospital
A/Professor Arun Aggarwal Balmain Hospital Nerve Conduction Studies Test to evaluate the function of motor / sensory nerves Evaluate Paraesthesia (numbness, tingling, burning) Weakness of arms and legs
More informationDiagnosis of Guillain Barré syndrome in children and validation of the Brighton criteria
J Neurol (2017) 264:856 861 DOI 10.1007/s00415-017-8429-8 ORIGINAL COMMUNICATION Diagnosis of Guillain Barré syndrome in children and validation of the Brighton criteria Joyce Roodbol 1,2 Marie-Claire
More informationTherapeutic Effect of Insulin in Reducing Critical Illness; Polyneuropathy and Myopathy in the Pediatric Intensive Care Unit
original ARTICLE Therapeutic Effect of Insulin in Reducing Critical Illness; Polyneuropathy and Myopathy in the Pediatric Intensive Care Unit How to Cite this Article: Bilan N, Sadegvand, Ranjbar Sh. Therapeutic
More informationValidity of Neurophysiological Study Inprediction of Severity of Guillain-Barre Syndrome and the Indication for Mechanical Ventilation
IOSR Journal Of Pharmacy And Biological Sciences (IOSR-JPBS) e-issn:2278-3008, p-issn:2319-7676. Volume 14, Issue 1 Ser. II (Jan Feb 2019), PP 43-47 www.iosrjournals.org Validity of Neurophysiological
More informationComparison of diabetes patients with demyelinating diabetic sensorimotor polyneuropathy to those diagnosed with CIDP
Comparison of diabetes patients with demyelinating diabetic sensorimotor polyneuropathy to those diagnosed with CIDP Samantha K. Dunnigan 1, Hamid Ebadi 1, Ari Breiner 1, Hans D. Katzberg 1, Leif E. Lovblom
More informationFunctional recovery of untreated human immunodeficiency virus-associated Guillain-Barré syndrome: A case report
Thomas Jefferson University Jefferson Digital Commons Department of Rehabilitation Medicine Faculty Papers Department of Rehabilitation Medicine 11-2011 Functional recovery of untreated human immunodeficiency
More informationDistal chronic spinal muscular atrophy involving the hands
Journal ofneurology, Neurosurgery, and Psychiatry, 1978, 41, 653-658 Distal chronic spinal muscular atrophy involving the hands D. J. O'SULLIVAN AND J. G. McLEOD From St Vincent's Hospital, and Department
More informationInfluenza vaccine and GBS
Influenza vaccine and GBS Tamar Lasky, PhD DHHS/NIH/NICHD Presented to the Institute of Medicine Immunization Safety Review Committee March 13, 2003 Guillain-Barré Syndrome and the 1992-93 and 1993-94
More informationCurrent treatment in Guillain-Barré Syndrome and myasthenia gravis
4 rd Congress of the European Academy of Neurology Lisbon, Portugal, June 16-19, 2018 Teaching Course 10 Current treatments in neurology Level 1 Current treatment in Guillain-Barré Syndrome and myasthenia
More informationGUILLAIN BARRE SYNDROME IN EARLY INFANCY: A CASE REPORT. Rajkumar M. Meshram*, S. Abhisheik, Hina Agrawal, Samadhan Dhakne Abstract
Paediatrics Case Report International Journal of Clinical And Diagnostic Research ISSN 2395-3403 Volume 4, Issue 6, Nov-Dec 2016. Glorigin Lifesciences Private Limited. GUILLAIN BARRE SYNDROME IN EARLY
More informationYing Wang 1*, Pei Shang 1, Meiying Xin 1, Jing Bai 1, Chunkui Zhou 1* and Hong-Liang Zhang 1,2*
Wang et al. BMC Neurology (2017) 17:200 DOI 10.1186/s12883-017-0982-3 RESEARCH ARTICLE Open Access The usefulness of chief complaints to predict severity, ventilator dependence, treatment option, and short-term
More informationWorld Journal of Pharmaceutical Research
World Journal of Pharmaceutical research Al-Aubaidy et al. Volume 3, Issue 2, XXX-XXX. Research Article ISSN 2277 7105 RESPONSE OF ANTI-CARDIOLIPIN ANTIBODIES TO VARIOUS TREATMENT MODALITIES IN GUILLAIN
More informationCase Classification West Nile Virus Neurological Syndrome (WNNS)
WEST NILE VIRUS Case definition Case Classification West Nile Virus Neurological Syndrome (WNNS) CONFIRMED CASE West Nile Virus Neurological Syndrome (WNNS) Clinical criteria AND at least one of the confirmed
More informationNeurologic Examination
John W. Engstrom, MD October 16, 2015 Neurologic Examination Overview The Neurologic Examination Neurologic Examination John W. Engstrom, M.D. Dept. of Neurology University of California, San Francisco
More informationSEMESTER Suriname study. The Suriname Meningo- encephalitis Study (SMS) Introduction. SMS- protocol version 3.4. Principal investigators:
SEMESTER Suriname study The Suriname Meningo- encephalitis Study (SMS) Principal investigators: E.C.M. van Gorp 1,2 and S. Vreden 3 Participating investigators: H. Alberga 4, M. Baptista 5, R. Cruden 4,
More informationThe clinical spectrum of Malaysian patients with. Chronic inflammatory demyelinating polyneuropathy
Neurology Asia 2004; 9 : 39 45 The clinical spectrum of Malaysian patients with chronic inflammatory demyelinating polyneuropathy Khean Jin GOH, Wai Keong NG, Nee Kong CHEW, Chong Tin TAN Division of Neurology,
More informationOutcome and its predictors in GuillaineBarré syndrome
1 Neuromuscular Clinic, Department of Neurology, University Hospitals of Leicester, Leicester, UK 2 Department of Neuroscience and Imaging, University G. d Annuzio, Chieti-Pescara, Italy Correspondence
More informationJMSCR Vol 04 Issue 12 Page December 2016
JMSCR Vol 04 Issue 12 Page 14551-14556 December 2016 www.jmscr.igmpublication.org Impact Factor 5.244 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v4i12.42
More informationAppendix B: Provincial Case Definitions for Reportable Diseases
Ministry of Health and Long-Term Care Infectious Diseases Protocol Appendix B: Provincial Case Definitions for Reportable Diseases Disease: West Nile Virus Illness Revised March 2017 West Nile Virus Illness
More informationPMH: No medications; Immunizations UTD No hospitalizations or surgeries Speech Delay. Birth Hx: 24 WGA, NICU x6 months
HPI: 6 months of weakness and parathesias- originally in both feet x 2-3 months, then resolved. Now with parathesias and weakness in fingers x 1 week. Seen by podiatrist and given custom in-soles 1 month
More information1/22/2019. Nerve conduction studies. Learning objectives: Jeffrey Allen MD University of Minnesota Minneapolis, MN
Jeffrey Allen MD University of Minnesota Minneapolis, MN February 9, 2019 Learning objectives: Describe electrophysiologic features of peripheral nerve demyelination Identify electrophysiology findings
More informationDiagnosis and Management of Immune-mediated Neuropathies
Continuing Medical Education 39 Diagnosis and Management of Immune-mediated Neuropathies Sung-Tsang Hsieh Abstract- Immune-mediate neuropathies, or inflammatory neuropathies are neuropathies due to the
More informationAhmed Abbas, Mark Cook, Liong Hiew Fu, Alistair Lewthwaite, Colin Shirley, Yusuf A. Rajabally
2016, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ Accepted Manuscript A case of POEMS mimicking
More informationA Brief History of Steroid Therapy for Guillain- Barré Syndrome
A Brief History of Steroid Therapy for Guillain- Barré Syndrome Xiang Ning, Yin Liyong, Lan Xifa * ABSTRACT Steroids have been used for the treatment of Guillain-Barré Syndrome (GBS) since the 1950s, while
More informationDiffuse myelitis in a 9-month-old infant: case report and review of the literature
230 La Revue de Santé de la Méditerranée orientale, Vol. 15, N 1, 2009 Case report Diffuse myelitis in a 9-month-old infant: case report and review of the literature O. Hüdaoglu,¹ U. Yis,¹ S. Kurul,¹ H.
More informationA Practical Approach to Polyneuropathy SLOCUM DICKSON ANNUAL TEACHING DAY NOVEMBER 4, 2017
A Practical Approach to Polyneuropathy SLOCUM DICKSON ANNUAL TEACHING DAY NOVEMBER 4, 2017 Disclosures Research support from Cytokinetics, Inc Catalyst, Inc Editorial fees from UptoDate. Objectives Describe
More informationGuillain Barré syndrome associated with normal or exaggerated tendon reflexes
J Neurol (2012) 259:1181 1190 DOI 10.1007/s00415-011-6330-4 ORIGINAL COMMUNICATION Guillain Barré syndrome associated with normal or exaggerated tendon reflexes Nobuhiro Yuki Norito Kokubun Satoshi Kuwabara
More informationGuillain-Barre Syndrome: A Retrospective Study of Clinical and Epidemiological Features in Kurdistan, West of Iran, From 2005 To 2014
International Journal of Epidemiologic Research doi:10.15171/ijer.2018.03 2018 Winter;5(1):9-13 http://ijer.skums.ac.ir Guillain-Barre Syndrome: A Retrospective Study of Clinical and Epidemiological Features
More informationHigh Yield Neurological Examination
High Yield Neurological Examination Vanja Douglas, MD Sara & Evan Williams Foundation Endowed Neurohospitalist Chair Director, Neurohospitalist Division Associate Professor of Clinical Neurology UCSF Department
More information